Science & Enterprise subscription

Follow us on Twitter

  • An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals li… https://t.co/AqWMpFYG5Q
    about 15 hours ago
  • New post on Science and Enterprise: Synthetic DNA Studied for Mass Data Storage https://t.co/XeKsILkGR0 #Science #Business
    about 15 hours ago
  • Engineers developed a more sustainable type of concrete adding a form of bacteria to grow and reproduce the materia… https://t.co/7naaOf9CYF
    about 19 hours ago
  • New post on Science and Enterprise: Living, Reproducing Concrete Created with Bacteria https://t.co/1RWPEfpvmz #Science #Business
    about 19 hours ago
  • Smart money? The US company receiving the most venture capital money through 2019 is e-cigarette maker Juul Labs, a… https://t.co/YHMyj4Aavo
    about 2 days ago

Please share Science & Enterprise

FDA Blocks Monthly HIV Drug Combo

T-cell infected by HIV

The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV. . . . → Read More: FDA Blocks Monthly HIV Drug Combo

FDA Approves Single Dual-Drug Pill for HIV

HIV released from cell

The Food and Drug Administration approved a daily pill with 2 drugs to lower viral loads in people with HIV, but who have not yet taken other HIV drugs. . . . → Read More: FDA Approves Single Dual-Drug Pill for HIV

Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Vaginal ring and PrEP

A clinical trial is underway testing use and preferences for drugs or a medical device to prevent HIV infection among young women and teenage girls in Africa. . . . → Read More: Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Infographic – HIV Infections Growing in Eastern Europe

Chart: HIV cases in Europe

While much attention is focused on the continuing AIDS and HIV crisis in Africa, countries in Eastern Europe are also facing growing numbers of HIV infections. . . . → Read More: Infographic – HIV Infections Growing in Eastern Europe

Antibody Combination Shown to Suppress HIV

T-cell infected by HIV

Results from a small-scale clinical trial show a combination of antibodies can suppress the HIV virus for many weeks after stopping antiretroviral therapy. . . . → Read More: Antibody Combination Shown to Suppress HIV

Technique Assessed for Comparing Effectiveness Between Drugs

Analytics

An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials. . . . → Read More: Technique Assessed for Comparing Effectiveness Between Drugs

HIV Drugs Formulated Into Once-Weekly Capsules

Medical and engineering researchers developed and tested in pigs a technique for packing several drugs into a capsule taken once a week to prevent and treat HIV infections. . . . → Read More: HIV Drugs Formulated Into Once-Weekly Capsules

Start-Up Lands $10M for Gene-Editing HIV Treatments

A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments

Gene Editing Could Lead to an HIV Cure

Researchers at Temple University and the University of Pittsburgh published a study, which involved gene editing to remove HIV DNA from rat and mouse models. . . . → Read More: Gene Editing Could Lead to an HIV Cure